Effect of regional crosstalk between sympathetic nerves and sensory nerves on temporomandibular joint osteoarthritic pain

Abstract

Temporomandibular joint osteoarthritis (TMJ-OA) is a common disease often accompanied by pain, seriously affecting physical and mental health of patients. Abnormal innervation at the osteochondral junction has been considered as a predominant origin of arthralgia, while the specific mechanism mediating pain remains unclear. To investigate the underlying mechanism of TMJ-OA pain, an abnormal joint loading model was used to induce TMJ-OA pain. We found that during the development of TMJ-OA, the increased innervation of sympathetic nerve of subchondral bone precedes that of sensory nerves. Furthermore, these two types of nerves are spatially closely associated. Additionally, it was discovered that activation of sympathetic neural signals promotes osteoarthritic pain in mice, whereas blocking these signals effectively alleviates pain. In vitro experiments also confirmed that norepinephrine released by sympathetic neurons promotes the activation and axonal growth of sensory neurons. Moreover, we also discovered that through releasing norepinephrine, regional sympathetic nerves of subchondral bone were found to regulate growth and activation of local sensory nerves synergistically with other pain regulators. This study identified the role of regional sympathetic nerves in mediating pain in TMJ-OA. It sheds light on a new mechanism of abnormal innervation at the osteochondral junction and the regional crosstalk between peripheral nerves, providing a potential target for treating TMJ-OA pain.

References

[1] Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review J. Can. Dent. Assoc., 2017, 83: h7

[2] Chantaracherd P, John MT, Hodges JS, Schiffman EL. Temporomandibular joint disorders’ impact on pain, function, and disability J. Dent. Res., 2015, 94: 79S-86S.

[3] Kalladka M, et al.. Temporomandibular joint osteoarthritis: diagnosis and long-term conservative management: a topic review J. Indian Prosthodont Soc., 2014, 14: 6-15.

[4] Perrot S. Osteoarthritis pain Best Pract. Res. Clin. Rheumatol., 2015, 29: 90-97.

[5] Dieppe PA, Lohmander LS, Lohmander. Pathogenesis and management of pain in osteoarthritis Lancet, 2005, 365: 965-973.

[6] Sun Q, et al.. Peripheral nerves in the tibial subchondral bone: the role of pain and homeostasis in osteoarthritis Bone Joint Res., 2022, 11: 439-452.

[7] Chung K, Yoon YW, Chung JM. Chung, Sprouting sympathetic fibers form synaptic varicosities in the dorsal root ganglion of the rat with neuropathic injury Brain Res., 1997, 751: 275-280.

[8] Vincent TL. Peripheral pain mechanisms in osteoarthritis Pain, 2020, 161: S138-S146.

[9] Ni S, et al.. Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice Nat. Commun., 2019, 10. 5643

[10] Qin WP, et al.. Effect of extracellular ribonucleic acids on neurovascularization in osteoarthritis Adv. Sci., 2023, 10. e2301763

[11] Malfait A-M, Schnitzer TJ. Towards a mechanism-based approach to pain management in osteoarthritis Nat. Rev. Rheumatol., 2013, 9: 654-664.

[12] Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications Arthritis Res. Ther., 2017, 19: 18.

[13] Eitner A, Wildemann B. Wildemann, diabetes—osteoarthritis and joint pain Bone Joint Res., 2021, 10: 307-309.

[14] Isaac D, et al.. Accelerated rehabilitation after total knee replacement Knee, 2005, 12: 346-350.

[15] Reilly KA, et al.. Efficacy of an accelerated recovery protocol for Oxford unicompartmental knee arthroplasty–a randomised controlled trial Knee, 2005, 12: 351-357.

[16] Bhosale AM, Richardson JB. Articular cartilage: structure, injuries and review of management Br. Med. Bull., 2008, 87: 77-95.

[17] Suri S, et al.. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis Ann. Rheum. Dis., 2007, 66: 1423-1428.

[18] Qin, W. et al. Effects of electric field‐modulated conductive hydrogel on osseoperception and osseointegration of dental implants. Adv. Funct. Mater. 34, 2400256 (2024).

[19] Jiang W, et al.. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis Bone Res., 2022, 10: 27.

[20] Jiao K, et al.. β2-Adrenergic signal transduction plays a detrimental role in subchondral bone loss of temporomandibular joint in osteoarthritis Sci. Rep., 2015, 5. 12593

[21] Sohn R, et al.. Adrenergic signalling in osteoarthritis Cell Signal., 2021, 82: 109948.

[22] Zanelatto FB, et al.. Anti-inflammatory effects of propranolol in the temporomandibular joint of female rats and its contribution to antinociceptive action Eur. J. Pain, 2018, 22: 572-582.

[23] Tchivileva IE, et al.. Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial Pain, 2020, 161: 1755-1767.

[24] Nakafero G, et al.. beta-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score-matched cohort study Rheumatology, 2021, 60: 5686-5696.

[25] Yan J, et al.. Autophagic LC3(+) calcified extracellular vesicles initiate cartilage calcification in osteoarthritis Sci. Adv., 2022, 8: eabn1556.

[26] Sun JL, et al.. Conditional deletion of Adrb2 in mesenchymal stem cells attenuates osteoarthritis-like defects in temporomandibular joint Bone, 2020, 133. 115229

[27] Jiao K, et al.. Norepinephrine regulates condylar bone loss via comorbid factors J. Dent. Res., 2015, 94: 813-820.

[28] Araya EI, et al.. Acute orofacial pain leads to prolonged changes in behavioral and affective pain components Pain, 2020, 161: 2830-2840.

[29] Wang Y, et al.. Microglia in the primary somatosensory barrel cortex mediate trigeminal neuropathic pain Neuroscience, 2019, 414: 299-310.

[30] Shrivastava M, Ye L. Neuroimaging and artificial intelligence for assessment of chronic painful temporomandibular disorders-a comprehensive review Int. J. Oral. Sci., 2023, 15: 58.

[31] Radulescu CI, et al.. Age-related dysregulation of homeostatic control in neuronal microcircuits Nat. Neurosci., 2023, 26: 2158-2170.

[32] Leithead AB, Godino A, Barbier M, Harony-Nicolas H, Harony-Nicolas. Social interaction elicits activity in glutamatergic neurons in the posterior intralaminar complex of the thalamus Biol. Psychiatry, 2024, 95: 112-122.

[33] Mach DB, et al.. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur Neuroscience, 2002, 113: 155-166.

[34] Xiao M, et al.. The expression of Netrin-1 in the MIA-induced osteoarthritic temporomandibular joint in mice Sci. Rep., 2021, 11. 15695

[35] Zhu S, et al.. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain J. Clin. Investig., 2019, 129: 1076-1093.

[36] Xue P, et al.. PGE2/EP4 skeleton interoception activity reduces vertebral endplate porosity and spinal pain with low-dose celecoxib Bone Res., 2021, 9: 36.

[37] Zheng B, et al.. Netrin-1 mediates nerve innervation and angiogenesis leading to discogenic pain J. Orthop. Translat., 2023, 39: 21-33.

[38] Prado NJ, et al.. Reperfusion arrhythmias increase after superior cervical ganglionectomy due to conduction disorders and changes in repolarization Int. J. Mo.l Sci., 2020, 21: 1804.

[39] Shen S, et al.. Beta 2-adrenergic receptor mediates noradrenergic action to induce cyclic adenosine monophosphate response element-binding protein phosphorylation in satellite glial cells of dorsal root ganglia to regulate visceral hypersensitivity Pain, 2022, 163: 180-192.

[40] Zheng Q, et al.. Synchronized cluster firing, a distinct form of sensory neuron activation, drives spontaneous pain Neuron, 2022, 110: 209-220.e206.

[41] Lin Q, et al.. Involvement of peripheral neuropeptide y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin Neuroscience, 2004, 123: 337-347.

[42] Chen SS, Zhang J-M. Progress in sympathetically mediated pathological pain J. Anesth. Perioper. Med., 2015, 2: 216-225.

[43] Davis KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain Pain, 1991, 47: 309-317.

[44] Ali Z, et al.. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain Pain, 2000, 88: 161-168.

[45] Marchand JE, Cepeda SM, Carr DB, Wurm HW, Kream RM. Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats Pain, 1999, 79: 187-200.

[46] Demas GE, Bartness TJ. Novel method for localized, functional sympathetic nervous system denervation of peripheral tissue using guanethidine J. Neurosci. Methods, 2001, 112: 21-28.

[47] Bossowska A, et al.. The Influence of an Adrenergic Antagonist Guanethidine on the Distribution Pattern and Chemical Coding of Caudal Mesenteric Ganglion Perikarya and Their Axons Supplying the Porcine Bladder Int. J. Mol. Sci., 2021, 22: 4869.

[48] Huang T, et al.. The effect of local sympatholysis on bone-tendon interface healing in a murine rotator cuff repair model J. Orthop. Translat., 2023, 40: 1-12.

[49] Sjoberg KA, et al.. GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism Cell Metab, 2023, 35: 1327-1340.e1325.

[50] Albillos A, Krag A. Beta-blockers in the era of precision medicine in patients with cirrhosis J. Hepatol., 2023, 78: 866-872.

[51] Reitman ME, et al.. Norepinephrine links astrocytic activity to regulation of cortical state Nat. Neurosci., 2023, 26: 579-593.

[52] Arendt-Nielsen L, et al.. Sensitization in patients with painful knee osteoarthritis Pain, 2010, 149: 573-581.

[53] Salaffi F, Ciapetti A, Carotti M. The sources of pain in osteoarthritis: a pathophysiological review Reumatismo, 2014, 66: 57-71.

[54] Yang D, et al.. Skeletal interoception in osteoarthritis Bone Res., 2024, 12: 22.

[55] Woolf CJ. What is this thing called pain? J. Clin. Invest., 2010, 120: 3742-3744.

[56] Brightwell JJ, Taylor BK. Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain Neuroscience, 2009, 160: 174-185.

[57] Kaushal R, et al.. GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex Neuroscience, 2016, 334: 148-159.

[58] Yen LD, Bennett GJ, Ribeiro-da-Silva A. Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury J. Comp. Neurol., 2006, 495: 679-690.

[59] Ramamoorthy P, Whim MD. Trafficking and fusion of neuropeptide Y-containing dense-core granules in astrocytes J. Neurosci., 2008, 28: 13815-13827.

[60] Sherpa AD, Xiao F, Joseph N, Aoki C, Hrabetova S. Activation of beta-adrenergic receptors in rat visual cortex expands astrocytic processes and reduces extracellular space volume Synapse, 2016, 70: 307-316.

[61] Shain W, Forman DS, Madelian V, Turner JN. Morphology of astroglial cells is controlled by beta-adrenergic receptors J. Cell. Biol., 1987, 105: 2307-2314.

[62] Xu HK, et al.. Region-specific sympatho-adrenergic regulation of specialized vasculature in bone homeostasis and regeneration iScience, 2023, 26. 107455

[63] Liu YD, et al.. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis Osteoarthr. Cartil., 2014, 22: 302-312.

Funding

National Nature Science Foundation of China 82471000 National Key Research and Development Program 2023YFC2509100 National Nature Science Foundation of China 82170978

RIGHTS & PERMISSIONS

The Author(s)